A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT

NCT05198323 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: LT3001 Drug Product
DRUG: Placebo

Sponsor

Lumosa Therapeutics Co., Ltd.